Vorinostat and b-cell lymphoma Patient Reports February 12, 2012

Vorinostat Side Effects Report #6091462-5
Vorinostat side effect was reported by a Physician from UNITED STATES on Feb 19, 2009. Male patient, 13 years of age, weighting 103.6 lb, was diagnosed with hodgkin's disease refractory and was treated with Vorinostat. After drug was administered, patient experienced the following side effects: b-cell lymphoma, epstein-barr virus associated lymphoproliferative disorder. Vorinostat dosage: 300 MG ONCE DAILY ORAL. During the same period patient was treated with ASPIRIN. Patient recovered.